Orchestra BioMed Holdings Cash Flow Statement (2022-2026) | OBIO

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -5.13M-7.63M-10.07M-9.83M-11.54M-12.96M-13.61M-11.37M-13.41M-15.96M-15.43M-16.16M-18.75M-19.36M-20.83M5.99M-22.90M
Depreciation and Depletion (Quarter) 0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M
Share-based Compensation (Quarter) 0.07M0.14M2.19M0.86M1.49M0.12M0.12M0.92M2.59M0.14M0.95M2.90M2.96M3.25M3.01M2.75M2.85M
Gains from Sales and Divestitures (Quarter) 0.06M0.07M0.08M0.01M0.02M0.14M0.42M0.18M0.63M0.92M1.21M0.22M
Gains from Investment Securities (Quarter) 0.14M1.01M-0.04M0.23M0.12M1.70M0.01M0.80M0.11M1.21M0.39M0.14M0.47M2.20M
Non-cash Items (Quarter) 7.40M6.60M10.60M8.19M5.70M2.95M3.31M0.00M6.60M0.69M0.36M1.96M4.46M
Cash from Operations (Quarter) -5.32M-7.96M-7.26M-8.74M-14.38M-10.49M-10.28M-10.97M-13.11M-10.21M-13.70M-13.54M-16.62M-15.53M-14.55M-2.27M-22.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.13M0.14M0.15M0.18M0.15M1.96M-1.65M3.35M0.05M0.17M0.28M1.00M0.15M0.15M0.15M0.16M0.08M
Amortization of Deferred Charges (Quarter) 0.06M0.04M0.04M0.04M0.04M0.04M0.04M0.00M0.05M0.05M0.06M0.06M0.06M
Depreciation & Amortization (CF) (Quarter) 0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.09M
Change in Working Capital
Change in Receivables (Quarter) -0.04M0.00M0.02M-0.02M0.10M-0.09M0.01M-0.03M0.01M0.04M-0.04M-0.00M-0.01M-0.03M0.04M-0.01M
Change in Inventory (Quarter) -0.04M0.10M0.20M-0.05M-0.04M-0.05M-0.04M0.01M-0.03M-0.04M0.16M-0.06M-0.04M0.05M0.18M-0.06M-0.03M
Change in Account Payables (Quarter) 0.10M0.07M0.11M0.10M
Change in Accured Expenses (Quarter) 0.20M0.47M1.62M1.06M-1.79M0.78M0.67M0.49M-1.28M3.73M1.23M-0.71M-0.20M1.09M3.41M0.57M-3.06M
Investing Activities
Capital Expenditures (Quarter) 0.05M0.27M0.22M0.05M0.04M0.03M0.02M-0.00M0.11M0.01M-0.09M0.26M0.11M0.03M0.31M-0.29M0.18M
Change in Acquisitions & Divestments (Quarter) 51.49M37.11M29.61M29.18M10.61M17.23M16.01M16.39M9.51M7.95M18.89M
Cash from Investing Activities (Quarter) -0.05M-0.47M-0.22M-63.38M-43.53M8.12M12.95M33.15M5.86M10.42M0.56M-3.75M13.00M16.36M-38.58M-17.71M10.32M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter) 1.00M5.45M
Change in Capital Stock
Shares Issued (Quarter) 0.03M0.05M0.04M0.00M0.02M0.21M0.02M0.17M14.85M-14.79M0.09M5.86M
Preferred Shares Issued (Quarter) 27.30M40.00M82.55M
Misc.
Cash from Financing Activities (Quarter) 24.76M86.08M-2.50M-5.09M56.82M0.09M0.00M-10.70M0.02M0.17M15.04M13.95M-0.30M-0.43M76.40M12.66M5.53M
Change in Cash (Quarter) 19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M
Free Cash Flow (Quarter) -5.37M-8.23M-7.48M-8.80M-14.42M-10.52M-10.30M-10.97M-13.22M-10.21M-13.61M-13.80M-16.73M-15.56M-14.86M-1.98M-22.35M
Net Cash Flow (Quarter) 19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M